Cargando…
Glucose abnormalities in Asian patients with chronic hepatitis C
Many studies have demonstrated a potential association between type 2 diabetes (T2D) and hepatitis C virus infection in Western countries, while similar evidence is limited in Asia. We compared the prevalence of glucose abnormalities (impaired fasting glucose [IFG] and T2D) and their risk factors be...
Autores principales: | Bo, Qingyan, Orsenigo, Roberto, Wang, Junyi, Griffel, Louis, Brass, Clifford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644176/ https://www.ncbi.nlm.nih.gov/pubmed/26609222 http://dx.doi.org/10.2147/DDDT.S92060 |
Ejemplares similares
-
Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials)
por: Kullak-Ublick, Gerd A., et al.
Publicado: (2014) -
Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients
por: Yuan, Man, et al.
Publicado: (2020) -
Growth Abnormalities in Children with Chronic Hepatitis B or C
por: Gerner, P., et al.
Publicado: (2012) -
Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C
por: Huang, Chao-Min, et al.
Publicado: (2017) -
Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
por: Ferrante, Shannon Allen, et al.
Publicado: (2013)